PROF
HEALTHCAREProfound Medical Corp
$7.22-0.05 (-0.69%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PROF Today?
No stock-specific AI insight has been generated for PROF yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.76$8.95
$7.22
Fundamentals
Market Cap$260M
P/E Ratio—
EPS$-1.41
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin-2.6%
Debt / Equity—
Trading
Volume56K
Avg Volume (10D)—
Shares Outstanding36.3M
PROF News
21 articles- Profound Medical Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Profound Medical (PROF) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 7, 2026
- Profound Medical Down 8.5% After Hours as Its Q1 Loss Narrows, Revenue More Than Doubles, Beats EstimatesYahoo Finance·May 7, 2026
- Profound Medical Reports Strong First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- Profound Medical Corp. (TSE:PRN) Is Expected To Breakeven In The Near FutureYahoo Finance·May 3, 2026
- Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat EstimatesYahoo Finance·Apr 30, 2026
- Profound Medical Showcases TULSA Data, AI Software Upgrades, and Reimbursement Tailwinds at ConferenceMarketbeat·Apr 25, 2026
- Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to FollowYahoo Finance·Apr 16, 2026
- Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor ConferenceYahoo Finance·Apr 14, 2026
- Profound Medical Corp. Investigated by the Portnoy Law FirmGlobeNewswire Inc.·Apr 9, 2026
- Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific MeetingYahoo Finance·Apr 1, 2026
- Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ MilestoneYahoo Finance·Mar 27, 2026
- Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?Yahoo Finance·Mar 26, 2026
- Profound Medical reports CAPTAIN trial meets primary safety endpointYahoo Finance·Mar 14, 2026
- CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary ContinenceYahoo Finance·Mar 13, 2026
- Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24Yahoo Finance·Mar 9, 2026
- Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic ...Yahoo Finance·Mar 6, 2026
- Profound Medical Q4 Earnings Call HighlightsMarketbeat·Mar 6, 2026
- Profound Medical (PROF) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Mar 5, 2026
- Profound Medical Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 5, 2026
- ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Yahoo Finance·Mar 2, 2026
All 21 articles loaded
Price Data
Open$7.22
Previous Close$7.27
Day High$7.36
Day Low$7.01
52 Week High$8.95
52 Week Low$3.76
52-Week Range
$3.76$8.95
$7.22
Fundamentals
Market Cap$260M
P/E Ratio—
EPS$-1.41
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin-2.6%
Debt / Equity—
Trading
Volume56K
Avg Volume (10D)—
Shares Outstanding36.3M
About Profound Medical Corp
Profound Medical Corp. The company is headquartered in Mississauga, Canada.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—